Double lumen design permits an airtight seal of the trachea and one bronchus. Color-coded cuff, pilot balloons, and proximal lumens help identify bronchial and tracheal lumens.
Double lumen design permits an airtight seal of the trachea and one bronchus. Color-coded cuff, pilot balloons, and proximal lumens help identify bronchial and tracheal lumens.
Double lumen design permits an airtight seal of the trachea and one bronchus. Color-coded cuff, pilot balloons, and proximal lumens help identify bronchial and tracheal lumens.
Double lumen design permits an airtight seal of the trachea and one bronchus. Color-coded cuff, pilot balloons, and proximal lumens help identify bronchial and tracheal lumens.
Double lumen design permits an airtight seal of the trachea and one bronchus. Color-coded cuff, pilot balloons, and proximal lumens help identify bronchial and tracheal lumens.
Double lumen design permits an airtight seal of the trachea and one bronchus. Color-coded cuff, pilot balloons, and proximal lumens help identify bronchial and tracheal lumens.
UltraTape's 1410 / 0140 is a permanent double sided foam cleanroom tape. The closed cell polyethylene foam is flexible to conform to uneven surfaces, and its strong adhesive makes it ideal for cleanroom construction and mounting.
UltraTape's 1410 / 0140 is a permanent double sided foam cleanroom tape. The closed cell polyethylene foam is flexible to conform to uneven surfaces, and its strong adhesive makes it ideal for cleanroom construction and mounting.
UltraTape's 1410 / 0140 is a permanent double sided foam cleanroom tape. The closed cell polyethylene foam is flexible to conform to uneven surfaces, and its strong adhesive makes it ideal for cleanroom construction and mounting.
UltraTape's 1410 / 0140 is a permanent double sided foam cleanroom tape. The closed cell polyethylene foam is flexible to conform to uneven surfaces, and its strong adhesive makes it ideal for cleanroom construction and mounting.
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC 50 s of 6, 2 and 4 nM for FGFR1 , VEGFR2 and Tie-2 .In VitroEOC317 (ACTB-1003) is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1 (IC